Cargando…
Accelerating patient access to oncology medicines with multiple indications in Europe
Background: In recent years, innovation in oncology has created new challenges for pricing and reimbursement systems. Oncology medicines with multiple indications face a number of access challenges: (1) the number of assessments and administrative burden; (2) aligning price to different values of th...
Autores principales: | Lawlor, R., Wilsdon, T., Darquennes, E., Hemelsoet, D., Huismans, J., Normand, R., Roediger, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381976/ https://www.ncbi.nlm.nih.gov/pubmed/34436506 http://dx.doi.org/10.1080/20016689.2021.1964791 |
Ejemplares similares
-
Access to innovative oncology medicines in Europe
por: Bergmann, L., et al.
Publicado: (2016) -
A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking
por: Lawlor, Ryan, et al.
Publicado: (2022) -
Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption
por: Poon, Charlotte, et al.
Publicado: (2023) -
Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer
por: Barron, Anthony, et al.
Publicado: (2016) -
Comparing access to orphan medicinal products in Europe
por: Zamora, Bernarda, et al.
Publicado: (2019)